LFCR · NASDAQ · Drug Manufacturers - Specialty & Generic

Lifecore Biomedical (LFCR)

Develops and manufactures sterile injectable products and pharmaceutical-grade hyaluronic acid.

$4.49
After hours−0.00 (−0.11%)
At close$4.50(+0.33%)

13F · 13D/G · Form 4

Institutions67.37%25.50M shares
104 holders · as of Jun 30, 2026
Insiders23.99%9.08M shares
13 holders · as of Jun 8, 2026
Strategic holders12.42%4.70M shares
1 holder · as of Oct 7, 2024
Adds to103.78%

37.85M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

These groups come from separate filings that can overlap, so they add to 103.78%; nothing is left for Other.

13F · 13D/G · Form 4

HolderStakeSharesDate
Nelson Obus1Insiderdirector
13.43%5.01Mfiled Jun 5, 2026
Wynnefield Capital IncInstitution
12.42%4.70Mas of Jun 30, 2026
Wynnefield Partners Small Cap Value LP IStrategic10 percent owner
12.42%4.70Mfiled Oct 7, 2024
Legion Partners Asset Management, LLCInstitution
11.79%4.46Mas of Jun 30, 2026
Greenhaven Road Investment Management, L.P.Institution
8.43%3.19Mas of Jun 30, 2026
325 Capital LLCInstitution
7.65%2.90Mas of Jun 30, 2026
BlackRock, Inc.Institution
5.32%2.01Mas of Jun 30, 2026
Scott MillerInsider
5.03%1.90Mfiled Jun 30, 2023
LW Capital Management, LLCInstitution
4.17%1.58Mfiled Feb 14, 2024
Vanguard Capital Management LLCInstitution
3.40%1.29Mas of Jun 30, 2026
Geode Capital Management, LLCInstitution
2.26%855,500as of Jun 30, 2026
Morgan StanleyInstitution
2.03%769,360as of Jun 30, 2026
State Street CorpInstitution
1.76%668,031as of Jun 30, 2026
Paul JosephsInsiderdirector, officer: Chief Executive Officer
1.57%592,915filed May 21, 2026
Quinn Opportunity Partners LLCInstitution
1.20%453,495as of Jun 30, 2026
DCF Advisers, LLCInstitution
1.12%424,500as of Jun 30, 2026
Ryan David LakeInsiderofficer: Chief Financial Officer
0.89%336,691filed Sep 4, 2025
Wittenberg Investment Management, Inc.Institution
0.83%314,015as of Jun 30, 2026
Aron R. EnglishInsider10 percent owner
0.70%264,180filed May 28, 2025
Northern Trust CorpInstitution
0.67%253,817as of Jun 30, 2026
Thomas D. SalusInsiderofficer: Chief Legal & Administration
0.65%246,333filed Apr 16, 2026
Vanguard Fiduciary Trust CoInstitution
0.63%239,924as of Jun 30, 2026
LPL Financial LLCInstitution
0.55%207,300as of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution
0.50%189,073as of Jun 30, 2026
Marshall Wace, LLPInstitution
0.47%177,471as of Jun 30, 2026
  1. Nelson Obus's transaction reports restate only vehicles that traded; the 2024 ownership statement (5.01M) plus the 75.4K net shares acquired since is used instead.

13F, as of Jun 30, 2026

104 holders · 25.50M shares · 17 new positions · 54 increased · 22 reduced · 20 closed

HolderShares% outstandingChg q/qFiled
Wynnefield Capital Inc4.70M12.42%0Aug 14, 2026
Legion Partners Asset Management, LLC4.46M11.79%0Aug 14, 2026
Greenhaven Road Investment Management, L.P.3.19M8.43%−346.8KAug 14, 2026
325 Capital LLC2.90M7.65%+733.4KAug 14, 2026
BlackRock, Inc.2.01M5.32%+135.8KAug 7, 2026
Vanguard Capital Management LLC1.29M3.40%−1.5KAug 13, 2026
Geode Capital Management, LLC855.5K2.26%+40.4KAug 12, 2026
Morgan Stanley769.4K2.03%+4.6KAug 13, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Legion Partners Holdings, LLCincl. White Raymond T., Legion Partners, L.P. I +4 more17.10%6.79M13DJul 2, 2026
Greenhaven Road Investment Management, L.P.9.80%3.62M13GFeb 14, 2025
22NW GP, Inc.incl. Aron R. English, Bryson O. Hirai-Hadley +4 more6.74%2.71M13DJul 2, 2026
BlackRock, Inc.5.40%2.01M13GJul 29, 2026

Form 4

Latest trades

No open-market trades in the last 12 months.

House and Senate disclosures

Not reported.